Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents: ORIGINAL ARTICLE

Fundamental and Clinical Pharmacology

Volumn 24, Issue 3, 2010, Pages 365-376

  Lalonde, Robert ^a,b   Strazielle, Catherine ^c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE ROUEN   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Anxiety; Elevated plus maze; Emergence test; Mouse strains; Open field

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BUSPIRONE; CHLORDIAZEPOXIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DOSE RESPONSE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CHLORDIAZEPOXIDE; EXPLORATORY BEHAVIOR; GABA MODULATORS; MAZE LEARNING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SEROTONIN RECEPTOR AGONISTS; SPECIES SPECIFICITY;

EID: 77952570157     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00772.x     Document Type: Article

References (55)

1. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol. Bull. (1976) 83 482 504.
2. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav. Brain Res. (2001) 125 151 157.
3. Graeff F.G., Guimarães F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. (1996) 54 129 141. (Pubitemid 26146666)
4. Paré W.P., Tejani-Butt S., Kluczynski J. The emergence test: effects of psychotropic drugs on neophobic disposition in Wistar Kyoto (WKY) and Sprague Dawley rats. Prog Neuropsychopharmacol. Biol. Psychiatry (2001) 25 1615 1628. (Pubitemid 33042701)
5. Dubinsky B., Vaidya A.H., Rosenthal D.I., et al. 5-ethoxymethyl-7-fluoro- 3-oxo-1,2,3,5-tetrahydrobenzo [4,5] imidazo[1,2a] pyridine-4-N-[2-fluorophenyl] carboxamide [RWJ-51204], a new nonbenzodiazepine anxiolytic. J. Pharmacol. Exp. Ther. (2002) 303 777 790. (Pubitemid 35231255)
6. Artaiz I., Romero G., Zazpe A. et al. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology (1995) 117 137 148.
7. Drapier D., Bentue-Ferrer D., Laviolle B., et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav. Brain Res. (2007) 176 202 209. (Pubitemid 44880083)
8. 1A receptor antagonists in three rat models of anxiety. Neuropharmacology (2000) 39 1848 1857. (Pubitemid 30398488)
9. B positive modulator CGP7930 in rodents. Neuropharmacology (2008) 54 854 862.
10. Langen B., Dietze S., Fink H. Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats. Alcohol (2002) 27 135 141. (Pubitemid 34754368)
11. Moreira C.M., Masson S., Carvalho M.C., Brandao M.L. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei. Brain Res. Bull. (2007) 71 466 474. (Pubitemid 46149197)
12. File S.E., Gonzalez L.E., Andrews N. Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. (1996) 16 4810 4815. (Pubitemid 26251075)
13. Silva R.C., Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol. Biochem. Behav. (2000) 65 209 216.
14. Martin J.R., Ballard T.M., Higgins G.A. Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety. Pharmacol. Biochem. Behav. (2002) 71 615 625.
15. 6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology (2007) 52 1274 1283. (Pubitemid 46527703)
16. 7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology (2006) 51 578 586. (Pubitemid 44215962)
17. 1B receptor stimulation in the rat elevated plus-maze. Pharmacol. Biochem. Behav. (2002) 71 581 587. (Pubitemid 34219208)
18. Koks S., Beljajev S., Koovit I., Abramov U., Bourin M., Vasar E. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology (2001) 153 365 372. (Pubitemid 32125821)
19. Belzung C., Le Guisquet A.M., Crestani F. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice. Psychopharmacology (2000) 148 24 32. (Pubitemid 30062469)
20. Belzung C., Le Guisquet A.M., Griebel G. Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice. Behav. Pharmacol. (2000) 11 125 131. (Pubitemid 30315847)
21. Elfline G.S., Branda E.M., Babich M., Quock R.M. Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze. Neuropsychopharmacology (2004) 29 1419 1425. (Pubitemid 38982233)
22. Rodgers R.J., Davies B., Shore R. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav. (2002) 1 242 251. (Pubitemid 36717670)
23. Rodgers R.J., Haller J., Halasz J., Mikics E. 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur. J. Neurosci. (2003) 17 1279 1286. (Pubitemid 36459782)
24. Rodgers R.J., Gentsch C., Hoyer D. et al. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze. Behav. Brain Res. (2004) 154 183 192. (Pubitemid 39070466)
25. Clénet F., Hascoët M., Fillion G., Galons H., Bourin M. Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety. Eur. Neuropsychopharmacol. (2004) 14 449 456. (Pubitemid 39642197)
26. Dalvi A., Rodgers R.J. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (1996) 128 380 397. (Pubitemid 26417680)
27. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (2000) 148 164 170. (Pubitemid 30104138)
28. Lepicard E.M., Joubert C., Hagneau I., Perez-Diaz F., Chapouthier G. Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice. Pharmacol. Biochem. Behav. (2000) 67 739 748. (Pubitemid 32144924)
29. Liu G.X., Cai G.Q., Cai Y.Q. et al. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology (2007) 32 1531 1539.
30. 1A receptor knockout mice on a 129/Sv background. Eur. J. Pharmacol. (2002) 447 67 74. (Pubitemid 34775222)
31. 3 receptor antagonist, in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. (2001) 69 571 578. (Pubitemid 32758743)
32. Nunes-de-Souza R.L., Canto-de-Souza A., da-Costa M., Fornari R.V., Graeff F.G., Pela I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology (2000) 150 300 310. (Pubitemid 30447850)
33. 2 ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Behav. Brain Res. (2007) 177 214 226. (Pubitemid 46149913)
34. Dere E., Topic B., De Souza Silva M.A. et al. The graded anxiety test: a novel test of murine unconditioned anxiety based on the principles of the elevated plus-maze and light-dark test. J. Neurosci. Methods (2002) 122 65 73. (Pubitemid 36132169)
35. Cao B.J., Rodgers R.J. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology (1997) 36 1089 1097.
36. Cao B.J., Rodgers R.J. Different behavioural profiles of the R(+)- and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino) tetralin in the murine elevated plus-maze. Behav. Pharmacol. (1996) 7 810 819. (Pubitemid 27219688)
37. Clénet F., Hascoët M., Fillion G., Galons H., Bourin M. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze. Behav. Brain Res. (2005) 158 339 348. (Pubitemid 40208481)
38. 2 ligands on three mouse models of anxiety. Behav. Brain Res. (2003) 140 203 214. (Pubitemid 36321745)
39. 2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav. Brain Res. (2003) 147 175 184. (Pubitemid 37492991)
40. 1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A. Pharmacol. Biochem. Behav. (1997) 58 583 591.
41. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav. (1997) 58 593 603.
42. 1A receptor antagonist, in the murine elevated plus-maze. Psychopharmacology (1997) 129 365 371.
43. Canto-de-Souza A., Luiz Nunes-de-Souza R., Rodgers R.J. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience. Brain Res. (2002) 928 50 59.
44. Nunes-de-Souza R.L., Canto-de-Souza A., Rodgers R.J. Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Res. (2002) 927 87 96.
45. Tecott L.H., Logue S.F., Wehner J.M., Kauer J.A. Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc. Natl. Acad Sci. USA (1998) 95 15026 15031.
46. iA receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology (2003) 28 2077 2088. (Pubitemid 37468176)
47. Jans L., Korte-Bouws G., Korte S., Blokland A. The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats. J. Psychopharmacol. (2008) PMID: 19074537.
48. Lalonde R., Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice. J. Neurosci. Methods (2008) 171 48 52.
49. Chapouthier G., Bondoux D., Martin B., Desforges C., Launay J.M. Genetic difference in sensitivity to beta-carboline: evidence for the involvement of brain benzodiazepine receptors. Brain Res. (1991) 553 342 346.
50. Carola V., D'Olimpio F., Brunamonti E., Mangia F., Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav. Brain Res. (2002) 134 49 57. (Pubitemid 34912685)
51. Depino A.M., Gross C. Simultaneous assesssment of autonomic function and anxiety-related behavior in BALB/c and C57BL/6 mice. Behav. Brain Res. (2007) 177 254 260. (Pubitemid 46149910)
52. Rogers D.C., Jones D.N.C., Nelson P.R. et al. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav. Brain Res. (1999) 105 207 217.
53. Avgustinovich D.F., Lipina T.V., Bondar N.P., Alekseyenko O.V., Kudryavtseva N.N. Features of the genetically defined anxiety in mice. Behav. Genet. (2000) 30 101 109.
54. Levay E.A., Paolini A.G., Govic A., Hazi A., Penman J., Kent S. Anxiety-like behaviour in adult rats perinatally exposed to maternal calorie restriction. Behav. Brain Res. (2008) 191 164 172.
55. Baker S., Chebli M., Rees S., Lemarec N., Godbout R., Bielajew C. Effects of gestational stress: 1. Evaluation of maternal and juvenile offspring behavior. Brain Res. (2008) 1213 98 110.